Nu Skin Enterprises Inc (NUS)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $191.31M
Last updated: Nov 17, 2026 at 4:24 PM ET
Nu Skin Enterprises Inc (NUS) Stock Chart
Nu Skin Enterprises (NUS) has a latest price of $3.80 on Nov 17, 2026. Its price fell 60.0% over the past 12 months. The month-end price fell 92.5% over the 10 years through Oct 2026, a compound annual decline of 22.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $82.42 in Sep 2018 and its lowest $4.53 in Sep 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NUS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NUS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 19.7%, and over 6 months it fell 31.8%. The month-end price fell 75.5% over the 3 years through Oct 2026, a compound annual decline of 37.4%.
| Period | Change |
|---|---|
| 1 month | -23.5% |
| 3 months | -19.7% |
| 6 months | -31.8% |
| 12 months | -60.0% |
| 12 months, with dividends | -57.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -75.5% | -37.4% |
| 5 years | -88.4% | -35.0% |
| 10 years | -92.5% | -22.8% |
Price by Year
Its best calendar year was 2017, when the price rose 42.8%, and its weakest was 2024, when it fell 64.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.65 | -51.7% |
| 2025 | $9.62 | +39.6% |
| 2024 | $6.89 | -64.5% |
| 2023 | $19.42 | -53.9% |
| 2022 | $42.16 | -16.9% |
| 2021 | $50.75 | -7.1% |
| 2020 | $54.63 | +33.3% |
| 2019 | $40.98 | -33.2% |
| 2018 | $61.33 | -10.1% |
| 2017 | $68.23 | +42.8% |
Trading Range
The price is 18.2% below its 50-day average of $4.65 and 35.8% below its 200-day average of $5.92.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.80 | |
| 50-day average | $4.65 | -18.2% |
| 200-day average | $5.92 | -35.8% |
Price Risk
Over 3 years, its largest fall from a peak was 80.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.79 |
| Largest fall, 1 year | -66.5% |
| Largest fall, 3 years | -80.5% |
Valuation
Nu Skin Enterprises traded at 3.0x earnings at the end of 2025, against a 5-year median of 8.6x and a 10-year median of 12.4x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NUS
What is NUS's 1-year price change?
Nu Skin Enterprises's price fell 60.0% over the past 12 months. With dividends included, the 12-month total return was -57.5%.
What is NUS's 5-year price change?
Nu Skin Enterprises's month-end price fell 88.4% over the 5 years through Oct 2026, a compound annual decline of 35.0%. These figures leave out dividends.
What is NUS's beta?
Nu Skin Enterprises's 1-year beta against the S&P 500 is 0.79, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 66.5%.
Is the NUS chart free?
Yes. Advanced Charting for NUS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NUS pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors